INC Research Provides Guidance on Regulatory Changes in India
Geoff Fatzinger Presents at Clinical Trials & Partnering India 2010
Raleigh NC, May 24, 2010 – INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, is proud to feature Geoff Fatzinger, executive director, Global Regulatory Affairs as a speaker in the Regulatory Overview & Enforcement track at IBC’s 2nd Annual Clinical Trials & Partnering India 2010 conference, May 24-25 in Mumbai.
Fatzinger will be presenting a session on “Charting a Course Through Shifting Global Regulatory Tides – How Sponsors can Plan Today for the Changes of Tomorrow” May 24 at 9:45 a.m. He will share the technological, scientific, ethical and economic changes are that converging on regulatory agencies in India and across the globe, as well as the challenges regulators face in various regions, such as how pandemic flu has forced a re-evaluation of import policies in Asia, and the impact on sponsors.
More importantly, Fatzinger willdiscuss ideas on how regulatory policies may adapt to meet these challenges and what those changes will mean for sponsors of global clinical trials. The presentation will highlight how clinical trial sponsors can be leaders, rather than followers, in establishing new standards to deal with changes that have outpaced established regulations.
INC Research offers a full spectrum of Phase I through IV global clinical trial services throughout India through its 50:50 joint venture with GVK Biosciences, India's premier contract research organization. Based in Gurgaon, a fast-growing business district on the outskirts of Delhi, the company has focused experience in CNS, oncology, infectious disease along with other therapeutic areas across adult and pediatric populations, and regulatory expertise to support and oversee regulatory submissions and clinical development strategy in the region.
About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.
### |
|
